Guide to Authors

Welcome to the electronic manuscript submission website for Bone Marrow Transplantation. The instructions below are structured so you can quickly and easily answer the following questions:

1. Is my manuscript suitable for Bone Marrow Transplantation? (Scope + Editorial Note)
2. How do I format my manuscript for Bone Marrow Transplantation? (Format of Papers)
3. How do I submit my manuscript to Bone Marrow Transplantation? (Submission of Papers)

OTHER LINKS

• About the journal
• Format of papers
• Preparation of Original Articles
• House style
• Submission of papers
• Editorial policy
• Ethics and bioethics
• Peer review policy
• Corrections
• About npg online services

ABOUT THE JOURNAL

Scope

Topics Covered
The editors will consider for publication all suitable papers dealing directly or indirectly with autologous or allogeneic transplantation of haemopoietic stem cells in experimental animals or man. Papers dealing with in vitro model systems will also be considered if they have obvious relevance to haemopoietic stem cell transplantation.

Editor	J M Goldman, UK
Frequency	24 issues a year
Abstracted in	Index Medicus/MEDLINE EMBASE/Excerpta Medica Current Contents/Clinical Medicine Elsevier BIOBASE/Current Awareness in Biological Sciences Reference Update SciSearch BIOSIS

Editorial Note

The editors will consider for publication manuscripts containing data already in press elsewhere or published previously in unreviewed format, such as abstracts or camera-ready papers for proceedings of scientific meetings. The new manuscript should differ from the one previously published and should not contain any identical Figures or Tables. It will be the responsibility of the senior author to bring to the editor's attention details of previous publications. The existence of such related paper(s) (published or in press) should be mentioned as a footnote to the manuscript or documented with appropriate references. The editorial decision will take account of the originality of the work submitted for publication and the extent to which readers of Bone Marrow Transplantation may be expected to have access to the book or journal in which the associated paper(s) have appeared.

A manuscript will be considered for publication on the understanding that:

• all named authors have agreed to its submission
• it is not currently being considered for publication by another journal
• if the paper is accepted it will not subsequently be published in the same or similar form in any language without the consent of publishers

Please note that Bone Marrow Transplantation no longer accepts Case Reports. Please consider submitting your report in the form of a Letter to the Editor.

FORMAT OF PAPERS

Article Types Table

Article Type	Description	Max Word Count
Original Article	These should follow the structure outlined below	We recommend a maximum of 3,000 words
Review	Scholarly reviews of topics within the scope of Bone Marrow Transplantation are commissioned and will be considered for publication after peer review.	We recommend a maximum of 4,000 words
Letters to the Editor	Correspondence is encouraged. Letters to the Editor may deal with subjects that have recently been addressed in the journal or may introduce new topics. In the former case the Editors may send the letter first to the authors of the original paper so that their comments may be published at the same time as the letter. Please include a standard title page with the title of the submission; the full names of the authors and their affiliations; the name, full postal address, telephone, fax and e-mail address of the author to whom correspondence and reprint requests are to be sent.	No more than 1000 words. Up to 10 References with a maximum of 2 Tables or Figures if necessary.
Commentary	Short overviews of new original work are published in this section. Text should be preceded by a brief sentence of 20-30 words that summarizes the article.
Editorials or Brief Reviews	Editorials or Brief Reviews will be solicited by the editors but suggestions for such material will be very welcome. Please email the journal office.
Solicited Reviews	Authors of commissioned reviews are requested to contact the Review Editor for further submission instructions. This does not apply to unsolicited reviews. Please contact Dr Hillard Lazarus at Hillard.Lazarus@case.edu.

Preparation of Original Articles

Abstract and Keywords
The abstract should not exceed 200 words and three to six keywords should be included to aid web searches after publication.

References
Only papers directly related to the article should be cited. Exhaustive lists should be avoided. References should follow the Vancouver format. In the text they should appear as numbers starting at one and at the end of the paper they should be listed (double-spaced) in numerical order corresponding to the order of citation in the text. All authors should be quoted for papers with up to six authors; for papers with more than six authors, the first six only should be quoted, followed by et al. Abbreviations for titles of medical periodicals should conform to those used in the latest edition of Index Medicus. The first and last page numbers for each reference should be provided. Abstracts and letters must be identified as such. Papers in press and papers already submitted for publication may be included in the list of references but no citation is required for work that is not yet submitted for publication.

Journal article, up to six authors:
Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6: 353–360.

Journal article, e-pub ahead of print:
Bonin M, Pursche S, Bergeman T, Leopold T, Illmer T, Ehninger G et al. F-ara-A pharmacokinetics during reduced-intensity conditioning therapy with fludarabine and busulfan. Bone Marrow Transplant 2007; e-pub ahead of print 8 January 2007; doi:10.1038/sj.bmt.1705565

Journal article, in press:
Gallardo RL, Juneja HS, Gardner FH. Normal human marrow stromal cells induce clonal growth of human malignant T-lymphoblasts. Int J Cell Cloning (in press).

Complete book:
Atkinson K, Champlin R, Ritz J, Fibbe W, Ljungman P, Brenner MK (eds). Clinical Bone Marrow and Blood Stem Cell Transplantation, 3rd edn. Cambridge University Press: Cambridge, 2004.

Chapter in book:
Coccia PF. Hematopoietic cell transplantation for osteopetrosis. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell Publishing Ltd: Malden, MA, 2004, pp 1443–1454.

Abstract:
Syrjala KL, Abrams JR, Storer B, Heiman JR. Prospective risk factors for five-year sexuality late effects in men and women after haematopoietic cell transplantation. Bone Marrow Transplant 2006; 37(Suppl 1): S4 (abstract 107).

Correspondence:
Caocci G, Pisu S. Overcoming scientific barriers and human prudence [letter]. Bone Marrow Transplant 2006; 38: 829–830.

EndNote users should select the Bone Marrow Transplantation output style for the correct reference style.

Personal communications must be allocated a number and included in the list of references in the usual way or simply referred to in the text; the authors may choose which method to use. In either case authors must obtain permission from the individual concerned to quote his/her unpublished work.

House Style

Standard abbreviations: Because the majority of readers will have experience in haematology and/or bone marrow transplantation, the journal will accept papers which use certain standard abbreviations, such as BMT, SAA or AML, without definition in the summary or in the text. However, authors are not obliged to omit the definitions. A list of standard abbreviations can be found here and here. Non-standard abbreviations should be defined in full at their first usage in the Summary and again at the first usage in the text, in the conventional manner.

Drug dosages: Authors are asked to take special care when specifying dosages of cytotoxic drugs. Abbreviations that are not internationally agreed, such as "bid" or "q12h", should be avoided. The risk of misinterpretation is reduced if the total dose or the total number of doses is specified in parentheses. Examples of recommended phraseology are:

1. Busulphan 4 mg/kg p.o. in divided doses daily for 4 days (total dose 16 mg/kg)
2. Cyclophosphamide 60 mg/kg once daily i.v. on days 1 & 2 (total dose 120 mg/kg)
3. Cytarabine 100 mg/m2 twice daily. i.v. for 4 consecutive days (total 8 doses)
4. Cytarabine 100 mg/m2 by continuous i.v. infusion over 12 hours for 5 consecutive days (total 10 doses)

Nevertheless readers are reminded that the ultimate responsibility for ensuring that any drug dosage is correct rests firmly with the clinician who prescribes the drug.

SUBMISSION OF PAPERS

Colour charges

Further information
To find out who to contact for advertising, subscriptions, permissions, papers in production or publishing a supplement, please visit our publisher’s contacts page. Alternatively, you can write to: Bone Marrow Transplantation, Nature Publishing Group, The Macmillan Building, 4 Crinan Street, London, N1 9XW, UK.

EDITORIAL POLICY

Statement of Ethics

Peer-review policy

Correction and retraction process

Non-Native Speakers of English
Researchers who are not native speakers of English who submit manuscripts to international journals sometimes receive negative comments from referees or editors about the English-language usage in their manuscripts, and these problems can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors to take at least one of the following steps:

• Have your manuscript reviewed for clarity by a colleague whose native language is English.
• Use one of the many English language editing services that are available, such as that offered by Nature Publishing Group Language Editing. An editor will improve the English to ensure that your meaning is clear and to identify problems that require your review.

Please note that the use of Nature Publishing Group Language Editing is at the author's own expense and in no way implies that the article will be selected for peer review or accepted by an NPG journal (or any other journal). The decisions that the editors of any NPG journal make based on the quality and suitability of a manuscript for that journal are entirely independent of whether that manuscript has been language-edited by Nature Publishing Group Language Editing.

Please press HOME to continue.